InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $5.860 0.21 (3.46%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$3,888 Application for quotation of securities - EMR 1 Dec 2023 6:31PM $2.800 $5.860 risen by 109.29%
$3,888 Change of Director's Interest Notice 1 Dec 2023 6:24PM $2.800 $5.860 risen by 109.29%
$3,888 Notification regarding unquoted securities - EMR 1 Dec 2023 6:22PM $2.800 $5.860 risen by 109.29%
$3,888 Results of Annual General Meeting 29 Nov 2023 3:24PM $2.740 $5.860 risen by 113.87%
$3,888 Annual General Meeting Presentation 29 Nov 2023 1:18PM $2.705 $5.860 risen by 116.64%
$3,888 Chairman's Address - 2023 Annual General Meeting 29 Nov 2023 12:55PM $2.705 $5.860 risen by 116.64%
$3,888 Recommended and Unconditional Takeover Offer Extended 24 Nov 2023 6:36PM $2.470 $5.860 risen by 137.25%
$3,888 Application for quotation of securities - EMR 24 Nov 2023 6:23PM $2.470 $5.860 risen by 137.25%
$3,888 Option Exercise 24 Nov 2023 6:23PM $2.470 $5.860 risen by 137.25%
$3,888 Application for quotation of securities - EMR 14 Nov 2023 9:38AM $2.460 $5.860 risen by 138.21%
$3,888 Option Exercise 14 Nov 2023 9:32AM $2.460 $5.860 risen by 138.21%
$3,888 Application for quotation of securities - EMR 13 Nov 2023 9:25AM $2.560 $5.860 risen by 128.91%
$3,888 Supplementary Target's Statement 9 Nov 2023 1:19PM $2.625 $5.860 risen by 123.24%
$3,888 Application for quotation of securities - EMR 1 Nov 2023 7:20PM $2.610 $5.860 risen by 124.52%
$3,888 Option Exercise 1 Nov 2023 7:20PM $2.610 $5.860 risen by 124.52%
$3,888 Second Supplementary Bidder's Statement 1 Nov 2023 3:59PM $2.620 $5.860 risen by 123.66%
$3,888 InvoCare Limited to be removed from the S&P/ASX 200 Index 31 Oct 2023 5:02PM $2.590 $5.860 risen by 126.25%
$3,888 Quarterly Report 31 Oct 2023 8:15AM $2.590 $5.860 risen by 126.25%
$3,888 Significant Exploration Results Continue at EMR Prospects 30 Oct 2023 2:47PM $2.605 $5.860 risen by 124.95%
$3,888 Recommended and Unconditional Takeover Offer Extended 27 Oct 2023 4:07PM $2.660 $5.860 risen by 120.30%
$3,888 Annual Report to shareholders 26 Oct 2023 11:17AM $2.675 $5.860 risen by 119.07%
$3,888 Letter to Shareholders - AGM Materials 26 Oct 2023 8:18AM $2.770 $5.860 risen by 111.55%
$3,888 Notice of Annual General Meeting/Proxy Form 26 Oct 2023 8:17AM $2.770 $5.860 risen by 111.55%
$3,888 Application for quotation of securities - EMR 13 Oct 2023 7:36PM $2.480 $5.860 risen by 136.29%
$3,888 Emerald Moves to 76.5% of Bullseye 13 Oct 2023 7:35PM $2.480 $5.860 risen by 136.29%

326 - 350 of 1043 results

Page 14 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.